Please join us via Zoom or use this streaming link. Presentations qualify for CME credit. To obtain your CME credit, you will need to use the Cloud CME system.
Systematic Approach to Treating “Polysubstance Use Disorder” 
Theresa Frey, PharmD, BCPP
Residency Director, Psychiatry
VA Madison Health Care
Ellen Lockard Edens, MD
Associate Professor, Psychiatry
Yale School of Medicine
Learning Objectives
- Utilize DSM-5 criteria and RIP-TEAR framework to assess a patient case.
- Stratify care priorities among multiple potential SUD/MH targets.
- Develop a treatment plan for a co-occurring SUD case.
Persons with a disability may request a reasonable accommodation, such as a sign language interpreter, by contacting us at 520-874-4082. Requests should be made as early as possible to allow time to arrange the accommodation.
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine - Tucson and Southern Arizona Veterans Affairs Health Care System The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Relevant Financial Relationships Statement(s):
University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.
| Name | Individual's role in activity | Nature of relationship(s) / Name of inelegible company(s) |
|---|---|---|
| Elisa Gumm, DO | Activity Director | Nothing to disclose - 11/07/2025 |
| Theresa Frey, PharmD, BCPP | Presenter | Coming soon |
| Ellen Lockard Edens, MD | Presenter | Coming soon |